In contrast to TERT promoter mutation, the prognostic impact of MGMT methylation was not dependent on other confounding factors including the status of TERT promoter mutation, emphasizing the important role of MGMT methylation as an independent prognostic marker in gliomas. The gene discussed is MGMT; the disease is glioma.